Actively Recruiting
Androgenic Alopecia TH07 Clinical Trial
Led by Triple Hair Inc · Updated on 2026-03-16
420
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn whether a new topical solution, TH07, can help treat androgenic alopecia in men and to learn more about its safety. Participants will be asked to apply either the TH07 solution, a standard hair growth treatment (Minoxidil 5%), or a placebo every day for 24 weeks. At the end of the study, hair growth will be compared in each group to determine which treatment is most effective at increasing hair count.
CONDITIONS
Official Title
Androgenic Alopecia TH07 Clinical Trial
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male aged 18 to 49 years at enrollment
- Diagnosis of androgenic alopecia stage III vertex to V on Hamilton Norwood Scale
- Body Mass Index between 19 and 35 kg/m2
- No systemic or topical treatment for androgenic alopecia in the last 90 days
- Willing to avoid other hair loss treatments, hair dyes, relaxers, new supplements, tattooing in target area, blood donations, OTC hair restorers, and exposure of pregnant partner to treated skin during the trial
- Willing to avoid participation in other drug or device trials during this study
- Allowed to use non-medicated and anti-dandruff shampoos and current vitamins/supplements
- Able and willing to provide written informed consent
- Has and is familiar with using a personal mobile phone (Android or iOS) with internet and email access
You will not qualify if you...
- History of scalp treatments such as hair transplant, hair weaving, laser or light therapy, micro-needling, intradermal therapy, PRP, or other surgical hair loss treatments within 6 months
- Hairstyles including shaved scalp or use of occlusive wigs, hair extensions, or non-breathable wigs
- Known or suspected allergy or hypersensitivity to trial medications
- Any severe or chronic medical condition that causes hair loss or affects study results
- History or likelihood of using excluded medicines
- History or diagnosis of specified medical conditions impacting hair
- Participation in any drug or device trial in the last 90 days
- Any other condition making patient unsuitable as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
YVR Aesthetic Training and Study Centre.
Vancouver, British Columbia, Canada, V5Z1H2
Actively Recruiting
Research Team
E
Edouard AL-Chami
CONTACT
L
Lori Hebert
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here